Skip to content

Loft prototypes new subject access request tool for health data

In January, we announced that we had received funding from the UK’s innovation agency, Innovate UK, to develop a fast and secure data pipeline for the MyEyeSite project. We can now report that we have successfully prototyped a Health Records Administration (HRA) interface. This new subject access request tool for health data will form an important part of the data pipeline we are building.

HRA is being integrated with MyEyeSite, the application for people with rare eye diseases which is the result of a collaboration between Loft, Moorfields Eye Hospital and UCL. When scans of a patient’s retinas are captured in a hospital’s medical imaging department, the HRA interface will make it possible to easily and efficiently add those images to the MyEyeSite platform for the patient’s benefit. From there, the patient can share their data with health professionals, and also consent for it to be made accessible to scientists studying rare eye conditions to advance their research.

By enabling patients with rare eye diseases to compile and share their health data, treatment can be delivered more efficiently, and researchers can be supplied with wider pools of valuable patient data which could help unlock improved ways of treating these conditions. As such, MyEyeSite aims to use technology to achieve better outcomes for patients.

“We hope MyEyeSite will be a groundbreaking for people with rare eye diseases, but the model we are developing could also serve as a platform to help people with other conditions,” says Nick Nettleton, founder and CEO at Loft. “We are pioneering a new way of managing patient health data which we think is very exciting for healthcare professionals, institutions and, most importantly, patients.”

There are many other possible uses for the HRA technology developed at Loft, both within and beyond rare disease treatment and research. We are looking for further partners to collaborate with – please get in touch if you think this subject access request tool could benefit a project you’re working on.

MyEyeSite has recently entered the open beta phase of its development. If successful, it will provide a template for future platforms that help people with other diseases, their doctors, health services and researchers, using technology to improve treatment and accelerate science around the world. Our HRA interface will play a key role as these new platforms develop.

Find out more about the project on the MyEyeSite website, or read our case study on the project here.

Date posted

20 May 2021


2 min read

More about our work in Health & wellness

Loft - Related posts

More in health & wellness

Loft - Post grid item

Loft joins Vantage to support digital health startups

Loft CEO Nick Nettleton is working with the tech startup accelerator Vantage on a new series of workshops tailored for company founders in the digital health space. The inaugural MedTech Growth Series will take place…

Read more

Loft - Post grid item

Diversity in Digital Health

Diversity is a key topic across the technology industry and an issue that throws up a variety of specific challenges in the digital health sector. To better understand these, raise awareness and explore some potential…

Read more

Loft - Post grid item

MyEyeSite academic paper published

A research paper focusing on the MyEyeSite project has been published in the UK, which helps demonstrate how technology can be used to benefit patients, improve treatment and advance medical research. Collaborating with Moorfields Eye…

Read more

Loft - Post grid item

Next digital health networking event – 30 November 2021

Run with our partners at Health Foundry, Loft’s digital health networking events are increasingly popular, particularly with so many of us itching to get out and meet industry colleagues again post-lockdown. Our next one could…

Read more

Learn more about our work in health & wellness

Take the next step with Loft

Learn how Loft can help solve your most challenging technology objectives.

Talk to an expert